Quest Diagnostics
DGX
#1099
Rank
โ‚น1.925 T
Marketcap
โ‚น17,219
Share price
-0.40%
Change (1 day)
31.53%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น785.10. In 2024 the company made an earnings per share (EPS) of โ‚น706.95 an increase over its 2023 EPS that were of โ‚น689.69.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.045.67%
2024โ‚น706.952.5%
2023โ‚น689.69-5.83%
2022โ‚น732.40-49.21%
2021โ‚น1,44249.72%
2020โ‚น963.2066.67%
2019โ‚น577.9218%
2018โ‚น489.78-4.26%
2017โ‚น511.5923.19%
2016โ‚น415.27-7.11%
2015โ‚น447.0728.46%
2014โ‚น348.02-31.61%
2013โ‚น508.8660.46%
2012โ‚น317.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น931.40 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น64.68-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.96-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.08-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น169.80-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands